Functional polymorphism in the 5′-UTR of CR2 is associated with susceptibility to nasopharyngeal carcinoma

Oncology Reports

Volumn 30, Issue 1, 2013, Pages 11-16

  Fan, Qin ^a   He, Jun Fang ^b,c   Wang, Qi Rui ^a   Cai, Hong Bing ^a   Sun, Xue Gang ^a   Zhou, Xin Xi ^b   Qin, Hai De ^b   Shugart, Yin Yao ^d   Jia, Wei Hua ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Case control study; Complement receptor 2; Nasopharyngeal carcinoma; Single nucleotide polymorphism; Susceptibility

Indexed keywords

COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 2; LUCIFERASE; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; CR2 GENE; FEMALE; GENE ACTIVITY; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

5' UNTRANSLATED REGIONS; ADULT; ALLELES; CASE-CONTROL STUDIES; CHINA; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, COMPLEMENT 3D;

EID: 84878201530     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2421     Document Type: Article

References (32)

1. Yu MC and Yuan JM: Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12: 421-429, 2002. (Pubitemid 35370755)
2. Chan TC, Teo ML and Johnson J: Nasopharyngeal carcinoma.Ann Oncol 13: 1007-1015, 2002.
3. Zhang XS, Wang HH, Hu LF, et al: V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma. Cancer Lett 211: 11-18, 2004.
4. Hu C, Wei W, Chen X, et al: A global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels. PLoS One 7: e41055, 2012.
5. Fujisaku A, Harley JB, Frank MB, Gruner BA, Frazier B and Holers VM: Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor. J Biol Chem 264: 2118-2125, 1989. (Pubitemid 19057681)
6. Hirunsatit R, Kongruttanachok N, Shotelersuk K, et al: Polymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancer. BMC Genet 4: 3, 2003.
7. Zheng Y, Zhang W, Ye Q, et al: Inhibition of Epstein-Barr virus infection by lactoferrin. J Innate Immun 4: 387-398, 2012.
8. Shao X, He Z, Chen Z and Yao K: Expression of an Epstein-Barr-virus receptor and Epstein-Barr-virus-dependent transformation of human nasopharyngeal epithelial cells. Int J Cancer 71: 750-755, 1997. (Pubitemid 27237194)
9. Wu H, Boackle SA, Hanvivadhanakul P, et al: Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Proc Natl Acad Sci USA 104: 3961-3966, 2007. (Pubitemid 47181561)
10. Cruickshank MN, Karimi M, Mason RL, et al: Transcriptional effects of a lupus-associated polymorphism in the 5′ untranslated region (UTR) of human complement receptor 2 (CR2/CD21). Mol Immunol 52: 165-173, 2012.
11. Simon K, Yang X, Munger K, et al: Variation in the Epstein-Barr virus receptor, CR2, and risk of multiple sclerosis. Mult Scler 13: 947-948, 2007. (Pubitemid 351540869)
12. Ghandri N, Gabbouj S, Farhat K, et al: Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome. Hum Immunol 72: 150-158, 2011.
13. Chen Y and Chan SH: Polymorphism of T-cell receptor genes in nasopharyngeal carcinoma. Int J Cancer 56: 830-833, 1994. (Pubitemid 24102749)
14. Jia WH, Pan QH, Qin HD, et al: A case-control and a family-based association study revealing an association between CYP2E1 polymorphisms and nasopharyngeal carcinoma risk in Cantonese. Carcinogenesis 30: 2031-2036, 2009.
15. He JF, Jia WH, Fan Q, et al: Genetic polymorphisms of TLR3 are associated with nasopharyngeal carcinoma risk in Cantonese population. BMC Cancer 7: 194, 2007.
16. Zhou XX, Jia WH, Shen GP, et al: Sequence variants in toll-like receptor 10 are associated with nasopharyngeal carcinoma risk. Cancer Epidemiol Biomarkers Prev 15: 862-866, 2006.
17. Cho EY, Hildesheim A, Chen CJ, et al: Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev 12: 1100-1104, 2003. (Pubitemid 37310270)
18. Wang G, Guo X and Floros J: Human SP-A 3′-UTR variants mediate differential gene expression in basal levels and in response to dexamethasone. Am J Physiol Lung Cell Mol Physiol 284: L738-L748, 2003. (Pubitemid 36459019)
19. Sham PC and Curtis D: Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59: 97-105, 1995.
20. Ng WT, Yau TK, Yung RW, et al: Screening for family members of patients with nasopharyngeal carcinoma. Int J Cancer 113: 998-1001, 2005. (Pubitemid 40096880)
21. Cheung F, Pang SW, Hioe F, et al: Nasopharyngeal carcinoma in situ: two cases of an emerging diagnostic entity. Cancer 83: 1069-1073, 1998. (Pubitemid 28419057)
22. Rajcani J and Kudelova M: Gamma herpesviruses: pathogenesis of infection and cell signaling. Folia Microbiol 48: 291-318, 2003. (Pubitemid 37030389)
23. Lohmueller KE, Pearce CL, Pike M, et al: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33: 177-182, 2003. (Pubitemid 36177070)
24. Wang G, Guo X and Floros J: Differences in the translation efficiency and mRNA stability mediated by 5′-UTR splice variants of human SP-A1 and SP-A2 genes. Am J Physiol Lung Cell Mol Physiol 289: 497-508, 2005.
25. Shalev A, Blair PJ, Hoffmann SC, et al: A proinsulin gene splice variant with increased translation efficiency is expressed in human pancreatic islets. Endocrinology 143: 2541-2547, 2002. (Pubitemid 34701317)
26. Kos M, Denger S, Reid G, et al: Upstream open reading frames regulate the translation of the multiple mRNA variants of the estrogen receptor alpha. J Biol Chem 277: 37131-37138, 2002.
27. Hua XJ, Van de Cotte B, Van Montagu M, et al: The 5′untranslated region of the At-P5R gene is involved in both transcriptional and post-transcriptional regulation. Plant J 26: 157-169, 2001. (Pubitemid 32532723)
28. Kebaara B, Nazarenus T, Taylor R, et al: The Upf-dependent decay of wild-type PPR1 mRNA depends on its 5′-UTR and first 92 ORF nucleotides. Nucleic Acids Res 31: 3157-3165, 2003. (Pubitemid 37441775)
29. Zou Z, Eibl C and Koop HU: The stem-loop region of the tobacco psbA 5′UTR is an important determinant of mRNA stability and translation efficiency. Mol Genet Genomics 269: 340-349, 2003. (Pubitemid 36831392)
30. Vagner S, Galy B and Pyronnet S: Irresistible IRES. Attracting the translation machinery to internal ribosome entry sites. EMBO Rep 2: 893-898, 2001. (Pubitemid 33040576)
31. Rubtsova MP, Sizova DV, Dmitriev SE, et al: Distinctive properties of the 5′-untranslated region of human hsp70 mRNA. J Biol Chem 278: 22350-22356, 2003. (Pubitemid 36830284)
32. Vereshchagina LA, Tolnay M and Tsokos GC: Multiple transcription factors regulate the inducible expression of the human complement receptor 2 promoter. J Immunol 166: 6156-6163, 2001. (Pubitemid 32440745)